PMID- 30013647 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230926 IS - 1792-1074 (Print) IS - 1792-1082 (Electronic) IS - 1792-1074 (Linking) VI - 16 IP - 2 DP - 2018 Aug TI - Delayed cognitive deficits can be alleviated by calcium antagonist nimodipine by downregulation of apoptosis following whole brain radiotherapy. PG - 2525-2532 LID - 10.3892/ol.2018.8968 [doi] AB - Radiation therapy is important for the comprehensive treatment of intracranial tumors. However, the molecular mechanisms underlying the pathogenesis of delayed cognitive dysfunction are not well-defined and effective treatments or prevention measures remain insufficient. In the present study, 60 adult male Wistar rats were randomly divided into three groups, which included a control, whole brain radiotherapy (WBRT) (single dose of 30 Gy of WBRT) and nimodipine (single dose of 30 Gy of WBRT followed by nimodipine injection intraperitoneally) groups. The rats were sacrificed 7 days or 3 months following irradiation. At 3 months, the Morris water maze test was used to assess spatial learning and memory function in rats. The results demonstrated that the WBRT group demonstrated a significantly impaired cognitive performance, decreased numbers of hippocampal Cornu Ammonis (CA)1 neurons and upregulated expression of caspase-3 in the dentate gyrus compared with those in the control and nimodipine groups. Reverse transcription-quantitative polymerase chain reaction analysis demonstrated that the WBRT group exhibited increased ratio of B-cell lymphoma 2 (Bcl-2)-associated X protein (Bax)/Bcl-2 compared with that in control and nimodipine groups on day 7 following irradiation. However, the WBRT group exhibited decreased levels of brain-derived neurotrophic factor (BDNF) compared with that in control and nimodipine groups at 3 months following brain irradiation. The levels of growth-associated protein 43 and amyloid precursor protein between the nimodipine group and WBRT group were not statistically significant. The present study demonstrated that neuron apoptosis may lead to delayed cognitive deficits in the hippocampus, in response to radiotherapy. The cognitive impairment may be alleviated in response to a calcium antagonist nimodipine. The molecular mechanisms involved in nimodipine-mediated protection against cognitive decline may involve the regulation of Bax/Bcl-2 and BDNF in the hippocampus. FAU - Tong, Jing AU - Tong J AD - Department of Neurosurgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China. FAU - Li, Juan AU - Li J AD - Department of Radiotherapy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China. FAU - Zhang, Qiu-Shi AU - Zhang QS AD - Department of Neurosurgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China. FAU - Yang, Jian-Kai AU - Yang JK AD - Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China. FAU - Zhang, Lei AU - Zhang L AD - Department of Neurosurgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China. FAU - Liu, Hai-Ying AU - Liu HY AD - Department of Neurosurgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China. FAU - Liu, Ying-Zi AU - Liu YZ AD - Department of Neurosurgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China. FAU - Yuan, Jiang-Wei AU - Yuan JW AD - Department of Neurosurgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China. FAU - Su, Xu-Ming AU - Su XM AD - Department of Neurosurgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China. FAU - Zhang, Xue-Xin AU - Zhang XX AD - Department of Neurosurgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China. FAU - Jiao, Bao-Hua AU - Jiao BH AD - Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China. LA - eng PT - Journal Article DEP - 20180613 PL - Greece TA - Oncol Lett JT - Oncology letters JID - 101531236 PMC - PMC6036595 OTO - NOTNLM OT - calcium antagonist OT - cognitive deficit OT - hippocampus OT - neuron apoptosis OT - rat OT - whole brain radiation therapy EDAT- 2018/07/18 06:00 MHDA- 2018/07/18 06:01 PMCR- 2018/06/13 CRDT- 2018/07/18 06:00 PHST- 2017/02/20 00:00 [received] PHST- 2018/01/29 00:00 [accepted] PHST- 2018/07/18 06:00 [entrez] PHST- 2018/07/18 06:00 [pubmed] PHST- 2018/07/18 06:01 [medline] PHST- 2018/06/13 00:00 [pmc-release] AID - OL-0-0-8968 [pii] AID - 10.3892/ol.2018.8968 [doi] PST - ppublish SO - Oncol Lett. 2018 Aug;16(2):2525-2532. doi: 10.3892/ol.2018.8968. Epub 2018 Jun 13.